Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
Randomized, Open-label, Controlled, Multicenter, Phase III Study in Previously Untreated Patients With Unresectable Stage IIIC or Stage IV Melanoma with V600E BRAF Mutation Receiving Vemurafenib (RO5185426) or Dacarbazine https://www.kusajili.fr:443/Trial/D4usCpZfr0WDfgYBpA2DPA%24randomized-open-label-controlled-multicenter-phase-iii-study-in-previously-untreated-patients-with-unresectable-stage-iiic-or-s
I have read and accept the terms of use of the site and the Privacy Policy
Send your message